MDR-001
A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants
MindRank AI Ltd · Phase 1/2 · Completed · Enrollment 128
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| MDR-001(SAD) | n/r | n/r | n/r | n/r |
| Placebo (SAD) | n/r | n/r | n/r | n/r |
| MDR-001 (MAD) | n/r | n/r | n/r | n/r |
| Placebo (MAD) | n/r | n/r | n/r | n/r |
Not shown
- MDR-001(SAD): endpoint not reported
- Placebo (SAD): endpoint not reported
- MDR-001 (MAD): endpoint not reported
- Placebo (MAD): endpoint not reported